(American Gastroenterological Society)
- Rifaximin Prophylaxis and “Collateral Damage” in Patients with Advanced Liver Disease
- In Memoriam: John S. Fordtran, MD
- Critical Analysis of Random Forest Feature Selection: Implications for Gut Microbiome Cancer Research
- Creeping Fat and Muscle Hyperplasia in Crohn’s Disease: A Critical Mechanistic Link for Stricture Formation
- ERCP-associated Risk of Death: How to Interpret and Mitigate?
- Reply to Antonelli et al, Wang et al, and He et al
- Comment on "Fecal Hemoglobin Levels in Prior Negative Screening and Detection of Colorectal Neoplasia: A Dose-Response Meta-Analysis"
- Reply to Kelm and Flemming and to Zhang et al
- Is PAaM Truly the Answer for Precise HCC Risk Stratification?
- The importance of the mesentery in the pathophysiology of Crohn’s disease
- Statistical Optimization in Dose-Response Meta-Analysis: Advancing FIT-Based Colorectal Neoplasia Risk Prediction
- Reply to Yang et al., He et al., and Mahapatra et al.
- Comments on “Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis”
- Advances in Locoregional and Systemic Treatments for HCC
- Gut Archaea in Colorectal Cancer Diagnosis and Ecology
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
